Monopar Therapeutics MNPR Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's earnings yield?
- Monopar Therapeutics (MNPR) reported earnings yield of -4.1% in Q1 2026.
- How has Monopar Therapeutics's earnings yield changed year-over-year?
- Monopar Therapeutics's earnings yield increased by 45.2% year-over-year, from -7.5% to -4.1%.
- What is the long-term trend for Monopar Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Monopar Therapeutics's earnings yield has grown at a 13.9% compound annual growth rate (CAGR), from -1.6% to -3.1%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.